Results
|
|
1.
|
|
|
|
2.
|
Evaluating the potential benefits of metformin in patients with cardiovascular disease and heart failure. MedStar authors:
- Amin, Shril M
- Chilipko, Allison A
- Macharia, David
- Norwood, Daryn K
- Still, Kimberly L
Year: 2013
Citation: - Consultant Pharmacist. 28(9):579-83, 2013 Sep.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Amin SM, Chilipko AA, Macharia D, Norwood DK, Still KL
|
|
|
3.
|
Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction. [Review] MedStar authors:
- Lam, Phillip H
- Patel, Jay
- Rassekh, Negin
- Sheikh, Farooq H
Year: 2023
Citation: - Drugs. 83(9):747-759, 2023 Jun.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Cardiovascular Disease Fellowship
Medline publication type:
All authors: - Ahmed A, Deedwania P, Fonarow GC, Lam PH, Patel J, Rassekh N, Sheikh FH
|
|
|
4.
|
SGLT2 inhibitors reduce sudden cardiac death risk in heart failure: Meta-analysis of randomized clinical trials. MedStar authors:
- Basyal, Binaya
- Oates, Connor
- Smith, Alex
Year: 2023
Citation: - Journal of Cardiovascular Electrophysiology. 34(5):1277-1285, 2023 May.
Institution: - MedStar Washington Hospital Center
Department: - Cardiovascular Disease Fellowship
Medline publication type:
All authors: - Basyal B, Dukkipati SR, Kawamura I, Koruth JS, Miller MA, Moss N, Musikantow DR, Oates CP, Reddy VY, Santos-Gallego CG, Smith A, Turagam MK, Whang W
|
